(Q51350450)

4 April 2018

title

Fasting apolipoprotein B48 is a marker for peripheral arterial disease in type 2 diabetes. (English)

1 reference

4 April 2018

1 reference

5

G Olivecrona

1 reference

4 April 2018

J Mancera-Romero

1

1 reference

4 April 2018

M A Sánchez-Chaparro

2

1 reference

4 April 2018

J Rioja

3

1 reference

4 April 2018

M J Ariza

4

1 reference

4 April 2018

P González-Santos

6

1 reference

4 April 2018

P Valdivielso

7

1 reference

4 April 2018

publication date

9 October 2012

1 reference

4 April 2018

published in

Acta Diabetologica

1 reference

4 April 2018

volume

50

1 reference

4 April 2018

issue

3

1 reference

4 April 2018

page(s)

383-389

1 reference

4 April 2018

https://scigraph.springernature.com/pub.10.1007/s00592-012-0434-x

exact match

0 references

cites work

Peripheral arterial disease in diabetes--a review

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0434-X

Effect of a multifactorial intervention on mortality in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0434-X

Retention of atherogenic lipoproteins in the artery wall and its role in atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0434-X

Association of fasting and nonfasting serum triglycerides with cardiovascular disease and the role of remnant-like lipoproteins and small dense LDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0434-X

Smoking and postprandial triglycerides are associated with vascular disease in patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0434-X

Postprandial apolipoprotein B48 is associated with asymptomatic peripheral arterial disease: a study in patients with type 2 diabetes and controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0434-X

Lipoprotein lipase: from gene to obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0434-X

Pre-heparin plasma lipoprotein lipase mass: correlation with intra-abdominal visceral fat accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0434-X

The lipoprotein lipase (LPL) S447X gain of function variant involves increased mRNA translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0434-X

The Edinburgh Claudication Questionnaire: an improved version of the WHO/Rose Questionnaire for use in epidemiological surveys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0434-X

Additive effects of LPL, APOA5 and APOE variant combinations on triglyceride levels and hypertriglyceridemia: results of the ICARIA genetic sub-study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0434-X

Significance of measuring serum concentrations of remnant lipoproteins and apolipoprotein B-48 in fasting period

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0434-X

Measurement of fasting serum apoB-48 levels in normolipidemic and hyperlipidemic subjects by ELISA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0434-X

Fasting APO B48 levels are associated with microalbuminuria in patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0434-X

Remarkable increase of apolipoprotein B48 level in diabetic patients with end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0434-X

Association of serum apolipoprotein B48 level with the presence of carotid plaque in type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0434-X

Exploring the value of apoB48 as a marker for atherosclerosis in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0434-X

Occult impaired glucose regulation in patients with atherosclerosis is associated to the number of affected vascular districts and inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0434-X

Dietary, physiological, genetic and pathological influences on postprandial lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0434-X

Measures of postprandial lipoproteins are not associated with coronary artery disease in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0434-X

Serum lipoprotein lipase mass: clinical significance of its measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0434-X

The relationship of serum lipoprotein lipase mass with fasting serum apolipoprotein B-48 and remnant-like particle triglycerides in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0434-X

Lipoprotein lipase in relation to inflammatory activity in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0434-X

Insulin sensitisation affects lipoprotein lipase transport in type 2 diabetes: role of adipose tissue and skeletal muscle in response to rosiglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0434-X

Preheparin serum lipoprotein lipase mass might be a biomarker of metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0434-X

10.1007/S00592-012-0434-X

21 January 2018

Identifiers

DOI

1 reference

4 April 2018

release_voyvllbn7bestlqloby2kaopn4

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/voyvllbn7bestlqloby2kaopn4

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

23053881

1 reference

4 April 2018